Geranylgeraniol potentiates lovastatin inhibition of oncogenic H-Ras processing and signaling while preventing cytotoxicity

Oncogene

Volumn 14, Issue 3, 1997, Pages 305-312

  McGuire, Terence F ^a   Sebti, Saïd M ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Geranylgeraniol; Lovastatin; Ras inhibition

Indexed keywords

GERANIOL; GERANYLTRANSFERASE; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031036845     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200819     Document Type: Article

References (38)

1. Adamson P, Marshall CJ, Hall A and Tilbrook PA. (1992). J. Biol. Chem., 267, 20033-20038.
2. Alberts AW. (1988). Am. J. Cardiol., 62, 10J-15J.
3. Bar-Sagi D and Feramisco JR. (1985). Cell, 42, 841-848.
4. Brown MS and Goldstein JL. (1980). J. Lipid Res., 21, 505-517.
5. Casey PJ. (1992). J. Lipid Res., 33, 1731-1740.
6. Casey PJ, Solski PA, Der CJ and Buss JE. (1989). Proc. Natl. Acad. Sci. USA, 86, 8323-8327.
7. Crick DC, Waechter CJ and Andres DA. (1994). Biochem. Biophvs. Res. Comm., 205, 955-961.
8. Der CJ and Cox AD. (1991). Cancer Cells, 3, 331-340.
9. Epstein WW, Lever DC and Rilling HC. (1990). Proc. Natl. Acad. Sci. USA, 87, 7352-7354.
10. Farnsworth CC, Gelb MH and Glomset JA. (1990). Science, 247, 320-322.
11. Fenton RG, Kung H-F, Longo DL and Smith MR. (1992). J. Cell Biol., 117, 347-356.
12. Fukada Y, Takao T, Ohguro H, Yoshizawa T, Akino T and Shimonishi Y. (1990). Nature, 346, 658-660.
13. Grünler J, Ericsson J and Dallner G. (1994). Biochim. Biophys. Acta., 1212, 259-277.
14. Hancock JF, Magee AI, Childs JE and Marshall CJ. (1989). Cell, 57, 1167-1177.
15. Holtz D, Tanaka RA, Hartwig J and McKeon F. (1989). Cell, 59, 969-977.
16. Hori Y, Kikuchi A, Isomura M, Katayama M, Miura Y, Fujioka H, Kaibuchi K and Takai Y. (1991). Oncogene, 6, 515-522.
17. Illingworth DR and Bacon S. (1989). Arterioscleriosis, 9, I-121-I-134.
18. Inglese J, Glickman JF, Lorenz W, Caron M and Lefkowitz RJ. (1992). J. Biol. Chem., 267, 1422-1425.
19. James GL, Goldstein JL and Brown MS. (1995). J. Biol. Chem., 270, 6221-6226.
20. Kato K, Cox AD, Hisaka MM, Graham SM, Buss JE, Der CJ. (1992). Proc. Natl. Acad. Sci. USA., 89, 6403-6407.
21. Leonard S, Beck L, Sinensky M. (1990). J. Biol. Chem., 265, 5157-5160.
22. Lerner EC, Qian, Y, Blaskovich MA, Fossum RD, Vogt A, Sun J, Cox AD, Der CJ, Hamilton AD and Sebti SM. (1995). J. Biol. Chem., 270, 26802-26806.
23. Lerner E, Qian Y, Hamilton AD and Sebti SM. (1995). J. Biol. Chem., 270, 26770-26773.
24. Maltese WA. (1990). FASEB J., 4, 3319-3328.
25. McCormick F. (1993). Nature, 363, 15-16.
26. McGuire TF, Corey S and Sebti SM. (1993). J. Biol. Chem., 268, 22227-22230.
27. Mulcahy LS, Smith MR and Stacey DW. (1985). Nature, 313, 241-243.
28. Nobes CD and Hall A. (1995). Cell, 81, 53-62.
29. Olson MF, Ashworth A and Hall A. (1995). Science, 269, 1270-1272.
30. Quesney-Huneeus V, Wiley MH and Siperstein MD. (1979). Proc. Natl. Acad. Sci. USA, 76, 5056-5060.
31. Reddy EP, Reynolds RK, Santos E and Barbacid M. (1982). Nature, 300, 149-152.
32. Reiss Y, Brown MS and Goldstein JL. (1992). J. Biol. Chem., 267, 6403-6408.
33. Sabine JR. (1983). CRC Press, Boca Raton FL.
34. Seabra MC, Reiss Y, Casey PJ, Brown MS and Goldstein JL. (1991). Cell, 65, 429-434.
35. Sebti SM, Tkalcevic GT and Jani JP. (1991). Cancer Comm., 3, 141-147.
36. Sinensky M and Logel J. (1985). Proc. Natl. Acad. Sci. USA, 82, 3257-3261.
37. Sun J, Qian Y, Hamilton AD and Sebti SM. (1995). Cancer Res., 55, 4243-4247.
38. Viganò T, Hernandez A, Corsini A, Granata A, Belloni P, Fumagalli R, Paoletti R and Folco G. (1995). Eur. J. Pharmacol., 291, 201-203.